These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
☐
|
|
Preliminary Proxy Statement
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
x
|
|
Definitive Proxy Statement
|
|
☐
|
|
Definitive Additional Materials
|
|
☐
|
|
Soliciting Material Pursuant to Rule §240.14a-12
|
|
x
|
|
No fee required.
|
|||
|
|
|
|
|||
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
|||
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
|
|
|
|
|
|
(2
|
)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
|
|
|
|
|
|
(3
|
)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
|
|
|
|
|
|
|
(4
|
)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
|
|
|
|
|
|
(5
|
)
|
|
Total fee paid:
|
|
|
|
|
|
|
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|||
|
|
|
|
|||
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|||
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
|
Amount Previously Paid:
|
|
|
|
|
|
|
|
|
|
|
(2
|
)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
|
|
|
|
|
|
(3
|
)
|
|
Filing Party:
|
|
|
|
|
|
|
|
|
|
|
(4
|
)
|
|
Date Filed:
|
|
|
|
|
|
|
|
|
(1)
|
To elect five directors to serve for a one-year term until the 2020 Annual Meeting of Stockholders or until a successor is duly elected and qualified;
|
|
(2)
|
To ratify the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2019;
|
|
(3)
|
To hold a non-binding advisory vote to approve our named executive officers’ compensation; and
|
|
(4)
|
To transact such other business as may properly come before the meeting or any adjournment or postponement of the meeting.
|
|
(1)
|
To elect five directors to serve for a one year term until the 2020 Annual Meeting of Stockholders or until a successor is duly elected and qualified (“Election of Directors Proposal”);
|
|
(2)
|
To ratify the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for year ending December 31, 2019 (“Ratification of Auditor Proposal”);
|
|
(3)
|
To hold a non-binding advisory vote to approve our named executive officers’ compensation (“Say on Pay Proposal”); and
|
|
(4)
|
To transact such other business as may properly come before the meeting or any adjournment or postponement of the meeting.
|
|
Name
|
Position
|
Director Since
|
|
Ryan Schulke
|
Director and Chief Executive Officer
|
2015
|
|
Peter Benz
|
Director
|
2015
|
|
Matthew Conlin
|
Director and President
|
2018
|
|
Andrew Frawley
|
Director
|
2018
|
|
Donald Mathis
|
Director
|
2015
|
|
Name
|
|
Stock awards (1)(6)
|
|
Other compensation
|
|
Total
|
||||||
|
Current Directors
|
|
|
|
|
|
|
||||||
|
Peter Benz (2)
|
|
$
|
153,250
|
|
|
$
|
50,000
|
|
|
$
|
203,250
|
|
|
Andrew Frawley (3)
|
|
$
|
66,250
|
|
|
$
|
33,750
|
|
|
$
|
100,000
|
|
|
Donald Mathis
(4)
|
|
$
|
66,250
|
|
|
$
|
45,000
|
|
|
$
|
111,250
|
|
|
|
|
|
|
|
|
|
||||||
|
Former Directors
|
|
|
|
|
|
|
||||||
|
Michael Brauser (5)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Robert Fried
(5)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Dr. Phillip Frost
(5)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Steven Rubin
(5)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Robert Swayman
(5)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
(1)
|
The amounts in this column represent the aggregate grant date fair value of RSU awards granted in 2018 computed in accordance with FASB ASC Topic 718. In determining the grant date fair value for RSUs, the Company used the closing price of the Company’s common stock on the grant date. For a discussion of valuation assumptions used in calculation of these amounts, see Note 12 to our audited financial statements, included within our 2018 Annual Report on Form 10-K.
|
|
(2)
|
Mr. Benz was granted 30,000 RSUs on March 8, 2018 at a fair value of $2.90 per share and 25,000 RSUs on March 27, 2018 at a fair value of $2.65 per share for his services as a director. Mr. Benz also received compensation of $50,000 in 2018 ($40,000 was for his services as a director and $10,000 was for his services as the Chairman of the Audit Committee).
|
|
(3)
|
Mr. Frawley was granted 25,000 RSUs on March 27, 2018 at a fair value of $2.65 for his services as director. Mr. Frawley also received compensation of $33,750 in 2018 ($30,000 was for his services as a director and $3,750 was for his services as the Chairman of the Corporate Governance and Nominating Committee).
|
|
(4)
|
Mr. Mathis was granted 25,000 RSUs on March 27, 2018 at a fair value of $2.65 for his services as director. Mr. Mathis also received compensation of $45,000 in 2018 ($40,000 was for his services as a director and $5,000 was for his services as the Chairman of the Compensation Committee).
|
|
(5)
|
While serving in their capacity as directors prior to the Spin-off, Mr. Brauser, Mr. Fried, Dr. Frost, Mr. Rubin and Mr. Swayman were not granted any stock awards or provided any compensation in 2018. In connection with Spin-off, on March 12, 2018, all unvested RSUs and shares of restricted stock held by Mr. Brauser, Mr. Fried, Dr. Frost, Mr. Rubin and Mr. Swayman were fully vested.
|
|
(6)
|
As of December 31, 2018, each director held RSUs as follows: Mr. Benz – 25,000, Mr. Frawley – 25,000, Mr. Mathis – 25,000.
|
|
|
|
2018
|
|
2017
|
||||
|
Audit Fees
|
|
$
|
827,864
|
|
|
$
|
849,076
|
|
|
Audit-Related Fees
|
|
—
|
|
|
297,260
|
|
||
|
Tax Fees
|
|
—
|
|
|
—
|
|
||
|
All Other Fees
|
|
—
|
|
|
—
|
|
||
|
Total
|
|
$
|
827,864
|
|
|
$
|
1,146,336
|
|
|
1.
|
The Audit Committee has reviewed and discussed the audited financial statements with management of the Company.
|
|
2.
|
The Audit Committee has discussed with Grant Thornton, our independent registered public accounting firm, the matters required to be discussed by Public Company Accounting Oversight Board Auditing Standard No. 1301,
Communications with Audit Committees.
|
|
3.
|
The Audit Committee has also received the written disclosures and the letter from Grant Thornton required by applicable requirements of the PCAOB regarding the independent accountant’s communications with the Audit Committee concerning independence and the Audit Committee has discussed the independence of Grant Thornton with that firm.
|
|
4.
|
Based on the review and discussion referred to in paragraphs (1) through (3) above, the Audit Committee recommended to the Board and the Board approved the inclusion of the audited financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018, for filing with the SEC.
|
|
Name
|
|
Age
|
|
Position
|
|
Ryan Schulke
|
|
36
|
|
Chief Executive Officer
|
|
Matthew Conlin
|
|
36
|
|
President
|
|
Alexander Mandel
|
|
49
|
|
Chief Financial Officer
|
|
Donald Patrick
|
|
58
|
|
Chief Operating Officer
|
|
Name and principal position
|
|
Year
|
|
Salary
|
|
Bonus
|
|
Stock awards (1)
|
|
Non-equity incentive plan compensation (2)
|
|
All other compensation (3)
|
|
Total
|
||||||||||||
|
Ryan Schulke
(4)
|
|
2018
|
|
$
|
296,667
|
|
|
$
|
125,000
|
|
|
$
|
1,480,800
|
|
|
$
|
401,857
|
|
|
$
|
5,933
|
|
|
$
|
2,310,257
|
|
|
(Chief Executive Officer)
|
|
2017
|
|
$
|
260,000
|
|
|
$
|
—
|
|
|
$
|
280,000
|
|
|
$
|
235,327
|
|
|
$
|
7,367
|
|
|
$
|
782,694
|
|
|
Matt Conlin
(5)
|
|
2018
|
|
$
|
296,667
|
|
|
$
|
125,000
|
|
|
$
|
1,480,800
|
|
|
$
|
401,857
|
|
|
$
|
11,000
|
|
|
$
|
2,315,324
|
|
|
(President)
|
|
2017
|
|
$
|
260,000
|
|
|
$
|
—
|
|
|
$
|
280,000
|
|
|
$
|
235,327
|
|
|
$
|
10,400
|
|
|
$
|
785,727
|
|
|
Donald Patrick
(6)
|
|
2018
|
|
$
|
294,318
|
|
|
$
|
—
|
|
|
$
|
459,750
|
|
|
$
|
371,757
|
|
|
$
|
8,000
|
|
|
$
|
1,133,825
|
|
|
(Chief Operations Officer)
|
|
2017
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Derek Dubner
(7)
|
|
2018
|
|
$
|
82,937
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
82,937
|
|
|
(Former Chief Executive Officer)
|
|
2017
|
|
$
|
325,000
|
|
|
$
|
—
|
|
|
$
|
2,395,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,720,000
|
|
|
(1)
|
The amounts in this column represent the aggregate grant date fair value of RSU awards granted in 2018 and 2017 computed in accordance with FASB ASC Topic 718. In determining the grant date fair value for restricted stock units, the Company used the closing price of the Company’s common stock on the grant date. For a discussion of valuation
|
|
(2)
|
Represents performance-based bonuses earned by our named executive officers in respect of our performance in fiscal years 2017 and 2018.
|
|
(3)
|
The amounts in this column represent the Company's 401(k) plan company-matching contributions for each officer.
|
|
(4)
|
Mr. Schulke began service as the Company's Chief Executive Officer following the Spin-off on March 27, 2018. Mr. Schulke was paid an annual bonus for 2018 and 2017 of
$1,480,800
and
$280,000
, respectively. Mr. Schulke was granted 80,000 RSUs on March 20, 2018 at a fair value of $2.61 per share, 480,000 deferred stock units in connection with the Spin-off on March 27, 2018 at a fair value of $2.65 and 50,000 RSUs on April 13, 2017 at a fair value of $5.60. Mr. Schulke additionally received a one-time cash bonus in connection with the Spin-off in 2018 of
$401,857
.
|
|
(5)
|
Mr. Conlin began service as the Company's President following the Spin-off on March 27, 2018. Mr. Conlin was paid an annual bonus for 2018 and 2017 of
$1,480,800
and
$280,000
, respectively. Mr. Conlin was granted 80,000 RSUs on March 20, 2018 at a fair value of $2.61 per share, 480,000 deferred stock units in connection with the Spin-off on March 27, 2018 at a fair value of $2.65 and 50,000 RSUs on April 13, 2017 at a fair value of $5.60. Mr. Conlin additionally received a one-time cash bonus in connection with the Spin-off in 2018 of
$401,857
.
|
|
(6)
|
Mr. Patrick began service as the Company's Chief Operations Officer following the Spin-off on March 27, 2018. Mr. Patrick's salary reflects his service from January 8, 2018 through December 31, 2018. Mr. Patrick was paid an annual bonus for 2018 of
$459,750
. Mr. Patrick was granted 100,000 RSUs on March 20, 2018 at a fair value of $2.61 per share and 75,000 deferred stock units in connection with the Spin-off on March 27, 2018 at a fair value of $2.65.
|
|
(7)
|
Mr. Dubner served as the Company’s Chief Executive Officer and director from March 9, 2016 through March 26, 2018. Mr. Dubner's salary for 2018 reflects his service from January 1, 2018 through March 26, 2018. Mr. Dubner was granted 125,000 RSUs on April 13, 2017 at a fair value of $5.60 per share and 300,000 shares of restricted stock on September 7, 2017 at a fair value of $5.65 per share.
|
|
Name
|
|
Stock awards
|
||||||
|
Number of shares or units of stock that have not vested (#)
|
|
Market value of shares or units of stock that have not
vested (5)
|
||||||
|
Ryan Schulke
|
|
333,333
|
|
(1)
|
|
$
|
1,199,999
|
|
|
Matt Conlin
|
|
333,333
|
|
(2)
|
|
$
|
1,199,999
|
|
|
Donald Patrick
|
|
100,000
|
|
(3)
|
|
$
|
360,000
|
|
|
Derek Dubner
|
|
—
|
|
(4)
|
|
$
|
—
|
|
|
(1)
|
Represents (i) 550,000 RSUs granted to Mr. Schulke under the 2015 Plan on December 8, 2015, which vest in increments of 30% on January 1, 2017 and January 1, 2018 and 40% on January 1, 2019, (ii) 50,000 RSUs granted on April 13, 2017, which vest in three equal annual installments beginning on February 1, 2018, and (iii) 80,000 RSUs granted on March 20, 2018, which vest in three equal annual installments beginning on March 1, 2019. Each RSU represents the right to receive one share of common stock upon vesting. The 680,000 RSUs held by Mr. Schulke as of December 31, 2018 include 346,667 shares that have been vested but not delivered.
|
|
(2)
|
Represents (i) 550,000 RSUs granted to Mr. Conlin under the 2015 Plan on December 8, 2015, which vest in increments of 30% on January 1, 2017 and January 1, 2018 and 40% on January 1, 2019, (ii) 50,000 RSUs granted on April 13, 2017, which vest in three equal annual installments beginning on February 1, 2018, and (iii) 80,000 RSUs granted on March 20, 2018, which vest in three equal annual installments beginning on March 1, 2019. Each RSU represents the right to receive one share of common stock upon vesting. The 680,000 RSUs held by Mr. Conlin as of December 31, 2018 include 346,667 shares that have been vested but not delivered.
|
|
(3)
|
Represents (i) 75,000 RSUs granted to Mr. Patrick under the 2015 Plan on March 20, 2018, which vest in three equal annual installments beginning on February 1, 2019, and (ii) 25,000 RSUs granted on March 20, 2018, which vest in three equal annual installments beginning on March 1, 2019. Each RSU represents the right to receive one share of common stock upon vesting.
|
|
(4)
|
Mr. Dubner did not have any shares or units of stock that remained unvested as of December 31, 2018, as all of his shares issued under the 2015 Plan were accelerated on March 27, 2018, the date of the Spin-off.
|
|
(5)
|
Determined by multiplying the closing price of the Company’s common stock on December 31, 2018, $3.60, by the number of shares of common stock underlying the RSUs or restricted stock.
|
|
Plan category
|
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights
(a)
|
|
Weighted average exercise price of outstanding options warrants and rights
(b)
|
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
(c)
|
||||||
|
Equity compensation plans approved by security holders
(1)
|
|
6,442,741
|
|
(2)
|
|
$
|
5.53
|
|
(3)
|
|
7,809,048
|
|
|
Equity compensation plans not approved by security holders
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
Total
|
|
6,442,741
|
|
|
|
$
|
5.53
|
|
|
|
7,809,048
|
|
|
(1)
|
The equity compensation plans approved by security holders include the 2008 Plan and 2015 Plan.
|
|
(2)
|
Includes 3,831,965 shares of RSUs and restricted stock to be issued upon the vesting of such RSUs and restricted stock.
|
|
(3)
|
The weighted-average exercise price does not reflect the shares that will be issued in connection with the vesting of RSUs and restricted stock, since RSUs and restricted stock have no exercise price.
|
|
Current Named Executive Officers and Current Directors/Nominees
|
|
Common Stock
Beneficially Owned
|
|
Percentage of
Common Stock
Beneficially
Owned
(1)
|
|
||
|
Current Named Executive Officers:
|
|
|
|
|
|
||
|
Ryan Schulke
|
|
9,199,932
|
|
(2)
|
12.0
|
%
|
|
|
Matthew Conlin
|
|
7,984,129
|
|
(3)
|
10.4
|
%
|
|
|
Alexander Mandel
|
|
—
|
|
(4)
|
*
|
|
|
|
Donald Patrick
|
|
108,334
|
|
(5)
|
*
|
|
|
|
Current Directors/Nominees:
|
|
|
|
|
|
||
|
Peter Benz
|
|
118,334
|
|
(6)
|
*
|
|
|
|
Andrew Frawley
|
|
8,334
|
|
(7)
|
*
|
|
|
|
Donald Mathis
|
|
58,334
|
|
(8)
|
*
|
|
|
|
All current Directors and Executive Officers as a group (7 persons)
|
|
15,477,397
|
|
(9)
|
20.2
|
%
|
(9)
|
|
5% Holders:
|
|
|
|
|
|
||
|
Dr. Phillip Frost
|
|
18,784,874
|
|
(10)
|
24.5
|
%
|
|
|
JB Capital Partners, L.P.
|
|
5,266,219
|
|
(11)
|
6.9
|
%
|
|
|
Wellington Trust Company, National Association
|
|
4,910,780
|
|
(12)
|
6.4
|
%
|
|
|
*
|
The person beneficially owns less than 1% of the Company’s outstanding common shares.
|
|
(1)
|
Based on 76,533,036 shares of common stock outstanding at April 26, 2018.
|
|
(2)
|
Mr. Schulke also serves a director of the Company. Mr. Schulke’s shares include (i) 7,199,932 shares held directly, (ii) 2,000,000 shares held by RSMC Partners, LLC, of which Mr. Schulke is a member, and do not include (i) 550,000 RSUs that vest over a three-year period of 30% on January 1, 2017, 30% on January 1, 2018 and 40% on January 1, 2019 but are subject to deferred delivery, (ii) 50,000 RSUs that vest in three annual installments beginning on February 1, 2018 but are subject to deferred delivery, (iii) 80,000 RSUs that vest in three annual installments beginning on March 1, 2019 but are subject to deferred delivery, and (iv) 320,000 deferred stock units that vested on March 27, 2018, subject to deferred delivery in two annual installments beginning on March 27, 2020. Mr. Schulke may be deemed to have shared voting control over the shares owned by Dr. Frost and Frost Gamma Investments Trust ("Frost Gamma") by virtue of a Stockholders’ Agreement entered into in connection with the Spin-off, pursuant to which Dr. Frost and Frost Gamma agreed to vote in favor of Mr. Schulke’s nominees for the the Company’s board of directors. This table does not reflect Mr. Schulke's ownership interest in these shares. If Mr. Schulke were deemed to have a beneficial ownership interest in these shares, Mr. Schulke would own 27,984,806 shares, or 36.6% of the Company's outstanding common shares.
|
|
(3)
|
Mr. Conlin also serves as a director of the Company. Mr. Conlin’s shares include (i) 5,300,229 shares held directly, (ii) 2,000,000 shares held by RSMC Partners, LLC, of which Mr. Conlin is a member, (iii) 663,900 shares held by GRAT, and (iv) 20,000 shares held by the Conlin Family Foundation Trust, and do not include (i) 550,000 RSUs that vest over a three-year period of 30% on January 1, 2017, 30% on January 1, 2018 and 40% on January 1, 2019 but are subject to deferred delivery, (ii) 50,000 RSUs that vest in three annual installments beginning on February 1, 2018 but are subject to deferred delivery, (iii) 80,000 RSUs that vest in three annual installments beginning on March 1, 2019 but are subject to deferred delivery, and (iv) 320,000 deferred stock units that vested on March 27, 2018, subject to deferred delivery in two annual installments beginning on March 27, 2020.
|
|
(4)
|
Mr. Mandel's shares do not include (i) 75,000 RSUs that vest in three annual installments beginning on February 1, 2020, (ii) 175,000 RSUs that vest in four annual installments, beginning on February 1, 2021, and (iii) 308,000 shares of common stock subject to options exercisable as early as February 1, 2020.
|
|
(5)
|
Mr. Patrick’s shares do not include (i) 50,000 RSUs that vest in three annual installments beginning on February 1, 2020, (ii) 16,666 RSUs that vest in two annual installments beginning on March 1, 2020, (iii) 50,000 deferred stock units that vested on March 27, 2018, subject to deferred delivery in two annual installments beginning on March 27, 2020, (iv) 225,000 RSUs that vest in four annual installments, beginning on February 1, 2021, and (v) 396,000 shares of common stock subject to options exercisable as early as February 1, 2020.
|
|
(6)
|
Mr. Benz’s shares do not include 16,666 RSUs that vest in two annual installments beginning on March 27, 2020.
|
|
(7)
|
Mr. Frawley’s shares do not include 16,666 RSUs that vest in two annual installments beginning on March 27, 2020.
|
|
(8)
|
Mr. Mathis’ shares do not include 16,666 RSUs that vest in two annual installments beginning on March 27, 2020.
|
|
(9)
|
The 2,000,000 shares held RSMC Partners, LLC, which are deemed beneficially owned by both Mr. Schulke and Mr. Conlin, are counted only once for this calculation.
|
|
(10)
|
Dr. Frost’s shares include 18,734,874 owned by Frost Gamma and 50,000 shares held by Dr. Frost directly, based on the Schedule 13D/A filed by Dr. Frost and Frost Gamma on February 14, 2019. Dr. Frost is the trustee of Frost Gamma. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. Frost Gamma’s address is 4400 Biscayne Blvd., Suite 1500, Miami, FL 33137. Dr. Frost and Frost Gamma may be deemed to share voting control of these shares with Mr. Schulke by virtue of the Stockholders' Agreement described in Note (2) above.
|
|
(11)
|
Based on the Schedule 13G/A filed by JB Capital Partners, L.P. and Alan W. Weber on February 14, 2019. Mr. Weber is the general partner of JB Capital Partners, L.P. and has shared dispositive power over these shares. The address for Mr. Weber and JB Capital Partners, L.P. is 5 Evans Place, Armonk, NY 10504.
|
|
(12)
|
Based on the Schedule 13G filed by Wellington Trust Company, National Association on February 12, 2019. The address for Wellington is 280 Congress Street, Boston, MA 02210.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|